Last 12 months
Inside the activity.
0 purchase rows · 33 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 1 |
| Dec 2025 | 0 | 2 |
| Jan 2026 | 0 | 2 |
| Feb 2026 | 0 | 4 |
| Mar 2026 | 0 | 5 |
| Apr 2026 | 0 | 2 |
| May 2026 | 0 | 3 |
| Jun 2026 | 0 | 3 |
| Jul 2026 | 0 | 3 |
| Aug 2026 | 0 | 5 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 1 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| December 01, 2025 Filed Dec 1, 2025 22:41 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 4,000 | $29.30 | $117,200.00 |
DisclosureSEC source: 0001520262-25-000012 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 65,740 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 21:37 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $19.34 | $0.00 |
DisclosureSEC source: 0001520262-25-000010 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 40,104 Underlying: Ordinary Shares · 5,000 shares Expires 2031-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 21:37 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 9,000 | $30.38 | $273,441.60 |
DisclosureSEC source: 0001520262-25-000010 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 69,740 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F3 · price: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $30.34 to $30.56. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| November 03, 2025 Filed Nov 3, 2025 21:37 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 5,000 | $19.34 | $96,700.00 |
DisclosureSEC source: 0001520262-25-000010 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 78,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. Read SEC document |
| October 15, 2025 Filed Oct 15, 2025 22:47 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,000 | $0.00 Strike: $19.34 | $0.00 |
DisclosureSEC source: 0001520262-25-000008 · form4.xml · derivative · entry 3 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 45,104 Underlying: Ordinary Shares · 5,000 shares Expires 2031-02-22 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F4 · derivative.exercise_date: These options are fully vested in accordance with their terms. Read SEC document |
| October 15, 2025 Filed Oct 15, 2025 22:47 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
SaleOrdinary Shares | 9,000 | $31.53 | $283,776.30 |
DisclosureSEC source: 0001520262-25-000008 · form4.xml · nonDerivative · entry 2 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 73,740 F2 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. F3 · shares: The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $31.51 to $31.60. Full information regarding the number of shares sold at each separate price can be provided to the issuer, any security holder of the issuer or the SEC staff upon request. Read SEC document |
| October 15, 2025 Filed Oct 15, 2025 22:47 UTC |
Hopkinson Craig C.EVP R&D, Chief Medical Officer
|
Exercise / conversionOrdinary Shares | 5,000 | $19.34 | $96,700.00 |
DisclosureSEC source: 0001520262-25-000008 · form4.xml · nonDerivative · entry 1 Hopkinson Craig C. · CIK 0001730048 · EVP R&D, Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 82,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: This option exercise was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/14/2025. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:41 UTC |
Reed JoshuaSVP, Chief Financial Officer
|
GrantRestricted Stock Unit Award · Derivative | 36,656 | $0.00 | $0.00 |
DisclosureSEC source: 0001520262-25-000006 · form4.xml · derivative · entry 2 Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 36,656 Underlying: Ordinary Shares · 36,656 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments, commencing on 10/8/2026. Read SEC document |
| October 08, 2025 Filed Oct 10, 2025 20:41 UTC |
Reed JoshuaSVP, Chief Financial Officer
|
GrantEmployee Stock Option (Right to Buy) · Derivative | 158,743 | $0.00 Strike: $31.51 | $0.00 |
DisclosureSEC source: 0001520262-25-000006 · form4.xml · derivative · entry 1 Reed Joshua · CIK 0001746541 · SVP, Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 158,743 Underlying: Ordinary Shares · 158,743 shares Expires 2035-10-08 F1 · derivative.exercise_date: Shares underlying the stock option vest and become exercisable in four equal annual installments, commencing on 10/8/2026. Read SEC document |
| August 03, 2025 Filed Aug 4, 2025 20:43 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 2,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-019974 · form4.xml · derivative · entry 3 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 2,015 Underlying: Ordinary Shares · 2,014 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 8/3/2023. F2 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in four equal annual installments commencing on 8/3/2023. Read SEC document |
| August 03, 2025 Filed Aug 4, 2025 20:43 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Tax withholdingOrdinary Shares | 895 | $26.55 | $23,762.25 |
DisclosureSEC source: 0001127602-25-019974 · form4.xml · nonDerivative · entry 2 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 205,374 Read SEC document |
| August 03, 2025 Filed Aug 4, 2025 20:43 UTC |
Gaffin David JosephEVP, CLO, Alkermes, Inc.
|
Exercise / conversionOrdinary Shares | 2,014 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-019974 · form4.xml · nonDerivative · entry 1 Gaffin David Joseph · CIK 0001675905 · EVP, CLO, Alkermes, Inc. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 206,269 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| June 10, 2025 Filed Jun 10, 2025 20:39 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
SaleOrdinary Shares | 3,334 | $31.09 | $103,654.06 |
DisclosureSEC source: 0001127602-25-017213 · form4.xml · nonDerivative · entry 2 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 86,208 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/10/2025. Read SEC document |
| June 09, 2025 Filed Jun 10, 2025 20:39 UTC |
Nichols Christian ToddSVP, Chief Commercial Officer
|
SaleOrdinary Shares | 3,333 | $31.95 | $106,489.35 |
DisclosureSEC source: 0001127602-25-017213 · form4.xml · nonDerivative · entry 1 Nichols Christian Todd · CIK 0001813312 · SVP, Chief Commercial Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 89,542 F1 · kind: This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on 3/10/2025. Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 20:37 UTC |
Wright Christopher IDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 3,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-017212 · form4.xml · derivative · entry 3 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 3,301 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 20:37 UTC |
Wright Christopher IDirector
|
Tax withholdingOrdinary Shares | 793 | $31.71 | $25,146.03 |
DisclosureSEC source: 0001127602-25-017212 · form4.xml · nonDerivative · entry 2 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,013 Read SEC document |
| June 08, 2025 Filed Jun 10, 2025 20:37 UTC |
Wright Christopher IDirector
|
Exercise / conversionOrdinary Shares | 3,301 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-017212 · form4.xml · nonDerivative · entry 1 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,806 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:33 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016206 · form4.xml · derivative · entry 3 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:33 UTC |
Wilson Frank AndersDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016206 · form4.xml · nonDerivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,084 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:33 UTC |
Wilson Frank AndersDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016206 · form4.xml · nonDerivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:31 UTC |
Lurker NancyDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016202 · form4.xml · derivative · entry 3 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:31 UTC |
Lurker NancyDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016202 · form4.xml · nonDerivative · entry 2 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,705 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:31 UTC |
Lurker NancyDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016202 · form4.xml · nonDerivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,629 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:30 UTC |
LAURENCIN CATO TDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016200 · form4.xml · derivative · entry 3 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:30 UTC |
LAURENCIN CATO TDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016200 · form4.xml · nonDerivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,102 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:30 UTC |
LAURENCIN CATO TDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016200 · form4.xml · nonDerivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,026 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
MCKEON BRIAN PDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016203 · form4.xml · derivative · entry 4 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
MCKEON BRIAN PDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016203 · form4.xml · nonDerivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,869 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
MCKEON BRIAN PDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016203 · form4.xml · nonDerivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 35,793 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:34 UTC |
Wright Christopher IDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016208 · form4.xml · derivative · entry 3 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:34 UTC |
Wright Christopher IDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016208 · form4.xml · nonDerivative · entry 2 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,505 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:34 UTC |
Wright Christopher IDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016208 · form4.xml · nonDerivative · entry 1 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 22,429 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016204 · form4.xml · derivative · entry 4 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: This award is fully vested in accordance with its terms. F3 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
snyderman nancy lynn MDDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016204 · form4.xml · nonDerivative · entry 2 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,728 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:32 UTC |
snyderman nancy lynn MDDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016204 · form4.xml · nonDerivative · entry 1 snyderman nancy lynn MD · CIK 0001675198 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 12,652 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:29 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016198 · form4.xml · derivative · entry 3 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:29 UTC |
GAYNOR RICHARDDirector
|
Tax withholdingOrdinary Shares | 1,924 | $30.61 | $58,893.64 |
DisclosureSEC source: 0001127602-25-016198 · form4.xml · nonDerivative · entry 2 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 31,084 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:29 UTC |
GAYNOR RICHARDDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016198 · form4.xml · nonDerivative · entry 1 GAYNOR RICHARD · CIK 0001741284 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 33,008 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:28 UTC |
Cooke ShaneDirector
|
Exercise / conversionRestricted Stock Unit Award · Derivative | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016196 · form4.xml · derivative · entry 3 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 Underlying: Ordinary Shares · 8,013 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. F2 · derivative.exercise_date: This award is fully vested in accordance with its terms. F2 · derivative.expiration_date: This award is fully vested in accordance with its terms. Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:28 UTC |
Cooke ShaneDirector
|
Tax withholdingOrdinary Shares | 4,175 | $30.61 | $127,796.75 |
DisclosureSEC source: 0001127602-25-016196 · form4.xml · nonDerivative · entry 2 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 103,744 Read SEC document |
| May 31, 2025 Filed Jun 2, 2025 20:28 UTC |
Cooke ShaneDirector
|
Exercise / conversionOrdinary Shares | 8,013 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001127602-25-016196 · form4.xml · nonDerivative · entry 1 Cooke Shane · CIK 0001524823 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 107,919 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Each restricted stock unit represents a contingent right to receive one ordinary share. Read SEC document |
| May 21, 2025 Filed May 23, 2025 22:00 UTC |
Wilson Frank AndersDirector
|
GrantRestricted Stock Unit Award · Derivative | 6,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015544 · form4.xml · derivative · entry 2 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142 Underlying: Ordinary Shares · 6,142 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 22:00 UTC |
Wilson Frank AndersDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 13,474 | $0.00 Strike: $30.53 | $0.00 |
DisclosureSEC source: 0001127602-25-015544 · form4.xml · derivative · entry 1 Wilson Frank Anders · CIK 0001462948 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,474 Underlying: Ordinary Shares · 13,474 shares Expires 2035-05-21 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:58 UTC |
Lurker NancyDirector
|
GrantRestricted Stock Unit Award · Derivative | 6,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015541 · form4.xml · derivative · entry 2 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142 Underlying: Ordinary Shares · 6,142 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:58 UTC |
Lurker NancyDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 13,474 | $0.00 Strike: $30.53 | $0.00 |
DisclosureSEC source: 0001127602-25-015541 · form4.xml · derivative · entry 1 Lurker Nancy · CIK 0001450485 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,474 Underlying: Ordinary Shares · 13,474 shares Expires 2035-05-21 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:57 UTC |
LAURENCIN CATO TDirector
|
GrantRestricted Stock Unit Award · Derivative | 6,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015540 · form4.xml · derivative · entry 2 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142 Underlying: Ordinary Shares · 6,142 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:57 UTC |
LAURENCIN CATO TDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 13,474 | $0.00 Strike: $30.53 | $0.00 |
DisclosureSEC source: 0001127602-25-015540 · form4.xml · derivative · entry 1 LAURENCIN CATO T · CIK 0001444810 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,474 Underlying: Ordinary Shares · 13,474 shares Expires 2035-05-21 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:59 UTC |
MCKEON BRIAN PDirector
|
GrantRestricted Stock Unit Award · Derivative | 6,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015542 · form4.xml · derivative · entry 2 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142 Underlying: Ordinary Shares · 6,142 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 21:59 UTC |
MCKEON BRIAN PDirector
|
GrantNon Qualified Stock Option (Right to Buy) · Derivative | 13,474 | $0.00 Strike: $30.53 | $0.00 |
DisclosureSEC source: 0001127602-25-015542 · form4.xml · derivative · entry 1 MCKEON BRIAN P · CIK 0001219445 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 13,474 Underlying: Ordinary Shares · 13,474 shares Expires 2035-05-21 F1 · derivative.exercise_date: Shares subject to the stock option award vest and become exercisable in full on 5/21/2026. Read SEC document |
| May 21, 2025 Filed May 23, 2025 22:01 UTC |
Wright Christopher IDirector
|
GrantRestricted Stock Unit Award · Derivative | 6,142 | $0.00 | $0.00 |
DisclosureSEC source: 0001127602-25-015545 · form4.xml · derivative · entry 2 Wright Christopher I · CIK 0001838503 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,142 Underlying: Ordinary Shares · 6,142 shares Expires not disclosed F2 · derivative.exercise_price: Each restricted stock unit represents a contingent right to receive one ordinary share. F3 · derivative.exercise_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. F3 · derivative.expiration_date: Shares subject to the restricted stock unit award vest in full on 5/21/2026. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.